Delivery Order SPE2DB20D3103-SPE2DB25FP9E0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This order, valued at $1,458.94, represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a $1,181.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proparacaine 0.5% eye drops (15 mL) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,481.14 to AmerisourceBergen Drug Corp for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 5, 2025. The award was issued on August 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Proparacaine 0.5% eye drops. The contract has a ceiling value of $2,959.98 and a performance period ending on July 1, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.95, is for the delivery of 15 ml bottles of Proparacaine 0.5% eye drops. The delivery order has a completion date of June 23, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of Proparacaine 0.5% eye drops, 15 mL, with a ceiling value of $1,118.70 and a period of performance through March 21, 2024. This order is issued under an indefinite delivery contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Proparacaine 0.5% eye drops. The fixed-price delivery order, valued at $1,895.81, has a completion date of November 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Proparacaine 0.5% eye drops in 15ml containers. The contract has a firm fixed price of $1,097.76 and a completion date of July 7, 2025. The contract is not set aside and was awarded on July 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. This contract is part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,019.16 Firm Fixed Price Delivery Order is for the supply of 4564339906 - Proparacaine 0.5% Eye Drops, 15ML. This contract has no set-aside designation and is for the ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $447.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561889381 Proparacaine 0.5% eye drops. The contract has a period of performance from August 21, 2023 through August 22, 2023 for product delivery from Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a major buyer of pharmaceuticals and medical supplies for the Department of Defense, this order for topical anesthetic eye drops from the Defense Logistics Agency...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9E0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Proparacaine 0.5% Eye Drops in 15ml quantities, with a ceiling value of $1,097.76. This firm fixed-price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition without set-aside restrictions, reflecting the contractor's established capability to meet federal pharmaceutical procurement requirements. Performance will be completed by August 18, 2025, with fulfillment based at the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for military and federal healthcare systems, providing a comprehensive portfolio of medications and medical supplies through its DLA contracts. The company's federal contracting demonstrates extensive experience delivering pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare programs. This delivery order for ophthalmic medication reflects the routine pharmaceutical supply requirements supporting military medical readiness and healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/15/25 |